DNA sequences encoding novel V31 seven transmembrane receptors and variance thereof are disclosed as well as materials and methods for production of the same by recombinant techniques. Antibody substances specific for V31 seven transmembrane receptors are disclosed as useful for the modulation of the ligand/receptor binding reactions of the receptors.
展开▼